NASDAQ:SCLX Scilex - SCLX Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Scilex Holding Please log in to your account or sign up in order to add this asset to your watchlist. $8.69 -0.12 (-1.36%) (As of 01/30/2023 04:21 PM ET) Add Compare Share Share Today's Range$8.17▼$9.9950-Day Range$2.87▼$11.3252-Week Range$2.87▼$11.69Volume347,730 shsAverage Volume531,233 shsMarket Capitalization$1.23 billionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileChartCompetitorsFinancialsHeadlinesSEC FilingsSocial Media About Scilex (NASDAQ:SCLX) StockScilex Holding Company, a biopharmaceutical company, focuses on developing and commercializing non-opioid management products for the treatment of acute and chronic pain. Its commercial product is ZTlido 1.8%, a prescription lidocaine topical product for the relief of neuropathic pain related with post-herpetic neuralgia, which is a form of post-shingles nerve pain. It also offers SP-102, a viscous gel formulation of corticosteroid for epidural injections that is in a Phase III clinical trial to treat lumbosacral radicular pain; SP-103, which is in Phase II clinical trail for the treatment of low back pain; and SP-104, a novel low-dose delayed-release naltrexone hydrochloride formulation that has completed Phase I clinical trial for the treatment of fibromyalgia. The company is headquartered in Palo Alto, California. Scilex Holding Company is a subsidiary of Sorrento Therapeutics, Inc.Read More Receive SCLX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Scilex and its competitors with MarketBeat's FREE daily newsletter. Email Address SCLX Stock News HeadlinesJanuary 14, 2023 | marketbeat.comMarketBeat: Week in Review 01/09-01/13 (SCLX)Markets are looking for direction in early trading before a holiday weekend. Here are some of the popular stories MarketBeat analysts were covering this week.January 12, 2023 | marketbeat.comSorrento Therapeutics, Scilex: 2 Hot Pharma Stocks On the Move (SCLX)Sorrento Therapeutics is on the move following preliminary results from its subsidiary Scilex. Scilex is making money with the company's 1st product to marketJanuary 30, 2023 | Porter & Company (Ad)Is This The End of Capitalism?EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…January 28, 2023 | americanbankingnews.comScilex (NASDAQ:SCLX) Trading 9.5% Higher January 28, 2023 | finance.yahoo.comWhy Shares of Scilex Soared This WeekJanuary 25, 2023 | americanbankingnews.comScilex (NASDAQ:SCLX) Stock Price Down 5%January 24, 2023 | seekingalpha.comA SPAC, Spinoff, And Short Squeeze Walk Into A BarJanuary 24, 2023 | seekingalpha.comRed Flags Waving As Scilex' Surprisingly High Valuation Starts To CorrectJanuary 30, 2023 | Porter & Company (Ad)Is This The End of Capitalism?EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…January 14, 2023 | barrons.comScilex Holding Co.November 17, 2022 | seekingalpha.comSCLX Scilex Holding CompanyNovember 17, 2022 | ca.finance.yahoo.comLoss-making Scilex Holding (NASDAQ:SCLX) sheds a further US$255m, taking total shareholder losses to 13% over 1 yearSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive SCLX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Scilex and its competitors with MarketBeat's FREE daily newsletter. Email Address SCLX Company Calendar Today1/30/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Biological products, except diagnostic Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:SCLX CUSIPN/A CIK1820190 Webwww.scilexholding.com Phone650 516 4310FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$780,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-16.72% Return on Assets1.34% Debt Debt-to-Equity RatioN/A Current Ratio0.20 Quick Ratio0.20 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash Flow$0.03 per share Price / Cash Flow330.03 Book Value($0.30) per share Price / Book-28.97Miscellaneous Outstanding Shares141,350,000Free Float113,079,000Market Cap$1.23 billion OptionableNot Optionable Beta-0.35 Key ExecutivesMr. Jaisim Shah (Age 63)Pres, CEO & Director Comp: $869.79kMr. Suresh K. Khemani (Age 63)Sr. VP & Chief Commercial Officer Comp: $456.82kDr. Dmitri V. Lissin M.D. (Age 64)Sr. VP & Chief Medical Officer Comp: $528.83kDr. Henry H. Ji Ph.D. (Age 59)Exec. Chairman Ms. Elizabeth Adkins Czerepak M.B.A. (Age 67)Exec. VP, CFO, Chief Bus. Officer & Sec. Dr. Suketu D. Desai Ph.D. (Age 58)Chief Technical Officer & Sr. VP Mr. Steven F. Lincoln J.D.Gen. Counsel & Chief Compliance OfficerMore ExecutivesKey CompetitorsNovavaxNASDAQ:NVAXSana BiotechnologyNASDAQ:SANAAnavex Life SciencesNASDAQ:AVXLREGENXBIONASDAQ:RGNXValnevaNASDAQ:VALNView All Competitors SCLX Stock - Frequently Asked Questions How have SCLX shares performed in 2023? Scilex's stock was trading at $3.99 at the beginning of the year. Since then, SCLX shares have increased by 111.5% and is now trading at $8.44. View the best growth stocks for 2023 here. What is Scilex's stock symbol? Scilex trades on the NASDAQ under the ticker symbol "SCLX." How do I buy shares of Scilex? Shares of SCLX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Scilex's stock price today? One share of SCLX stock can currently be purchased for approximately $8.44. How much money does Scilex make? Scilex (NASDAQ:SCLX) has a market capitalization of $1.19 billion. How can I contact Scilex? Scilex's mailing address is 1 Harbourfront Avenue #16-06 Keppel Bay Tower, Singapore U0, 098632. The official website for the company is www.scilexholding.com. The company can be reached via phone at 650 516 4310. This page (NASDAQ:SCLX) was last updated on 1/30/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.